Division of Biomaterials and Bioengineering, Department of Preventive and Restorative Dental Sciences, University of California, Parnassus Avenue 707, San Francisco, CA 94143, USA.
Arch Oral Biol. 2011 Dec;56(12):1548-59. doi: 10.1016/j.archoralbio.2011.06.016. Epub 2011 Jul 20.
In the following respects, tooth enamel is a unique tissue in the mammalian body: (a) it is the most mineralized and hardest tissue in it comprising up to 95 wt% of apatite; (b) its microstructure is dominated by parallel rods composed of bundles of 40-60 nm wide apatite crystals with aspect ratios reaching up to 1:10,000 and (c) not only does the protein matrix that gives rise to enamel guides the crystal growth, but it also conducts its own degradation and removal in parallel. Hence, when mimicking the process of amelogenesis in vitro, crystal growth has to be coupled to proteolytic digestion of the amelogenin assemblies that are known to play a pivotal role in conducting the proper crystal growth. Experimental settings based on controlled and programmable titration of amelogenin sols digested by means of MMP-20 with buffered calcium and phosphate solutions were employed to imitate the formation of elongated, plate-shaped crystals. Whilst amelogenin can act as a promoter of nucleation and crystal growth alone, in this study we show that proteolysis exerts an additional nucleation- and growth-promoting effect. Hydrolysis of full-length amelogenin by MMP-20 decreases the critical time needed for the protein and peptides to adhere and to cover the substrate. The formation and immobilization of a protein layer subsequently reduces the time for calcium phosphate crystallization. Coupling the proteolytic reaction to titration in the presence of 0.4 mg/ml rH174 has been shown to have the same effect on the crystal growth promotion as quadrupling the concentration of rH174 to 1.6 mg/ml. Controlling the rate and the extent of the proteolytic cleavage can thus be used to control the nucleation and growth rates in a protein-guided crystallization system.
在以下几个方面,牙釉质是哺乳动物体内一种独特的组织:(a)它是最矿化和最坚硬的组织,由高达 95wt%的磷灰石组成;(b)其微观结构由平行的棒状结构主导,由束状的 40-60nm 宽的磷灰石晶体组成,纵横比高达 1:10000;(c)不仅赋予釉质结构的蛋白质基质指导晶体生长,而且还平行地进行自身的降解和去除。因此,在体外模拟釉质形成过程时,晶体生长必须与对釉原蛋白组装体的蛋白水解消化相偶联,已知釉原蛋白组装体在引导适当的晶体生长中起关键作用。采用基于 MMP-20 消化的釉原蛋白溶胶的受控和可编程滴定的实验设置,并用缓冲钙和磷酸盐溶液模拟长而薄的晶体的形成。虽然釉原蛋白本身可以作为成核和晶体生长的促进剂,但在本研究中我们表明,蛋白水解还具有额外的成核和生长促进作用。MMP-20 对全长釉原蛋白的水解作用降低了蛋白和肽附着和覆盖基底所需的关键时间。随后形成和固定蛋白质层会减少磷酸钙结晶所需的时间。在存在 0.4mg/ml rH174 的情况下将蛋白水解反应与滴定偶联已被证明对晶体生长促进具有与将 rH174 的浓度提高到 1.6mg/ml 相同的效果。因此,控制蛋白水解反应的速率和程度可以用于控制蛋白引导的结晶系统中的成核和生长速率。